This activity is supported by educational grants from Takeda Pharmaceuticals International, Inc., US Region and Orexigen Therapeutics, Inc; Eisai, Inc.; Novo Nordisk; Vivus, Inc.
Management of obesity is complex, factoring in psychological, environmental, and physiologic causes. Treatment options… More »
Meeting News Coverage Video
March 31, 2015
SAN FRANCISCO — In this video, Iltefat Hamzavi, MD, FAAD, senior staff physician at Henry Ford Hospital… More »
Several pharmacologic options for the management of obesity have been approved by the US FDA, giving clinicians a range… More »